|
|
Article: Phytomedics Inc. Receives Second Round of Equity Investment From Poalim Investments Ltd.
- Article from:
- PR Newswire
- Article date:
- September 7, 2000
CopyrightCOPYRIGHT 2000 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
DAYTON, N.J., Sept 7 /PRNewswire/ --
Phytomedics Inc. is very pleased to announce that it has just received a second round of equity investment from Poalim Investments Ltd., one of Israel's largest financial enterprises and a leader among the investment industry.
Poalim Investments Ltd. is also a limited partner in the BioTech M.A.H. Plant Genomic Fund, jointly run by Makhteshim-Agan Industries Ltd., a leading agricultural chemical company, and Hazera Quality Seeds Ltd., Israel's leading seed company, who previously announced a strategic relationship with Phytomedics in January.
"We are very pleased about the continued equity investment into ...